The present and future burden of previously treated advanced non-small cell lung cancer (NSCLC) by histology and line of therapy in France, Germany, Italy, and Spain: model-based predictions
The burden of advanced non-small cell lung cancer (NSCLC) is not well understood, and the number of patients likely to receive treatment in Europe has not been quantified. The aim of this study was to forecast...
Source: Population Health Metrics - Category: Epidemiology Authors: David Campbell, Ken O ’Day, Nadine Hertel, John R. Penrod, Melinda Manley Daumont and Michael Lees Tags: Research Source Type: research
More News: Cancer | Cancer & Oncology | Epidemiology | France Health | Germany Health | Italy Health | Lung Cancer | Non-Small Cell Lung Cancer | Spain Health | Study